Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
We ask MIT’s Vander Heiden to delineate science from engineering—and NCI from ARPA-H
Conversation with The Cancer Letter

We ask MIT’s Vander Heiden to delineate science from engineering—and NCI from ARPA-H
“The lines are much more blurred in terms of what’s an engineering problem and what’s a basic science problem.”

April 23, 2021
Vol.47 No.16
By Matthew Bin Han Ong and Paul Goldberg
Chernobyl: a 35 year follow up on long-term health effects
Cancer History ProjectFreeGuest Editorial

Chernobyl: a 35 year follow up on long-term health effects

April 23, 2021
Vol.47 No.16
By Robert Peter Gale
Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it”
NCI

Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it”

April 16, 2021
Vol.47 No.15
By Matthew Bin Han Ong
The Moonshot’s Metric for Success: Avoiding a Single, Tangible Endpoint
Free

The Moonshot’s Metric for Success: Avoiding a Single, Tangible Endpoint

June 24, 2016
Vol.42 No.25

Posts navigation

Previous1…4041

Trending Stories

  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • California’s Prop 38 is an historic approach to funding medical research, immunology
    The $8.4B bond makes a long-term investment in a field with life-saving power
  • Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
    Her endowed award will live on
  • NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
    New NOFO aims to shrink applications by 40%
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
  • Facing stage 4 cholangiocarcinoma, Keaton Herzer moved mountains to take off-label therapy, get a transplant
    Two years later, he has no evidence of disease

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account